Matrix metalloproteinases and minocycline: Therapeutic avenues for fragile X syndrome

Neural Plasticity

Volumn 2012, Issue , 2012, Pages

  Siller, Saul S ^a,b   Broadie, Kendal ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; MINOCYCLINE; MATRIX METALLOPROTEINASE INHIBITOR; PROTEINASE INHIBITOR;

AUTISM; BENIGN CHILDHOOD EPILEPSY; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; FRAGILE X SYNDROME; HUMAN; HYPERACTIVITY; INTELLECTUAL IMPAIRMENT; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; REVIEW; ANIMAL; DISEASE MODEL; DROSOPHILA; ENZYMOLOGY; GENETICS; MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; DROSOPHILA; FRAGILE X SYNDROME; HUMANS; MATRIX METALLOPROTEINASE INHIBITORS; MATRIX METALLOPROTEINASES; MICE; MINOCYCLINE; PROTEASE INHIBITORS;

EID: 84862336959     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2012/124548     Document Type: Review

References (115)

1. Koukoui S. D., Chaudhuri A., Neuroanatomical, molecular genetic, and behavioral correlates of fragile X syndrome Brain Research Reviews 2007 53 1 27 38 (Pubitemid 44854210)
2. Crawford D. C., Acuna J. M., Sherman S. L., FMR1 and the fragile X syndrome: human genome epidemiology review Genetics in Medicine 2001 3 5 359 371
3. Hagerman P. J., The fragile X prevalence paradox Journal of Medical Genetics 2008 45 8 498 499
4. Garber K. B., Visootsak J., Warren S. T., fragile X syndrome European Journal of Human Genetics 2008 16 6 666 672 (Pubitemid 351753362)
5. Penagarikano O., Mulle J. G., Warren S. T., The pathophysiology of fragile X syndrome Annual Review of Genomics and Human Genetics 2007 8 109 129
6. Merenstein S. A., Sobesky W. E., Taylor A. K., Riddle J. E., Tran H. X., Hagerman R. J., Molecular-clinical correlations in males with an expanded FMR1 mutation American Journal of Medical Genetics 1996 64 2 388 394
7. Brown W. T., Jenkins E. C., Cohen I. L., fragile X and autism: a multicenter survey American Journal of Medical Genetics 1986 23 1-2 341 352 (Pubitemid 16139739)
8. Cornish K., Sudhalter V., Turk J., Attention and language in fragile X Mental Retardation and Developmental Disabilities Research Reviews 2004 10 1 11 16 (Pubitemid 38375348)
9. Einfeld S., Hall W., Levy F., Hyperactivity and the fragile X syndrome Journal of Abnormal Child Psychology 1991 19 3 253 262
10. Elia M., Ferri R., Musumeci S. A., Del Gracco S., Bottitta M., Scuderi C., Miano G., Panerai S., Bertrand T., Grubar J. C., Sleep in subjects with autistic disorder: a neurophysiological and psychological study Brain and Development 2000 22 2 88 92 (Pubitemid 30155633)
11. Hagerman R. J., Jackson A. W., Levitas A., An analysis of autism in fifty males with the fragile X syndrome American Journal of Medical Genetics 1986 23 1-2 359 374 (Pubitemid 16139741)
12. Kaufmann W. E., Cortell R., Kau A. S. M., Bukelis I., Tierney E., Gray R. M., Cox C., Capone G. T., Stanard P., Autism spectrum disorder in fragile X syndrome: communication, social interaction, and specific behaviors American Journal of Medical Genetics A 2004 129 3 225 234 (Pubitemid 39166187)
13. Miano S., Bruni O., Elia M., Scifo L., Smerieri A., Trovato A., Verrillo E., Terzano M. G., Ferri R., Sleep phenotypes of intellectual disability: a polysomnographic evaluation in subjects with Down syndrome and Fragile-X syndrome Clinical Neurophysiology 2008 119 6 1242 1247
14. Tsiouris J. A., Brown W. T., Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy CNS Drugs 2004 18 11 687 703 (Pubitemid 39243564)
15. Chudley A. E., Hagerman R. J., fragile X syndrome Journal of Pediatrics 1987 110 6 821 831 (Pubitemid 17080426)
16. Hagerman R. J., Van Housen K., Smith A. C. M., McGavran L., Consideration of connective tissue dysfunction in the fragile X syndrome American Journal of Medical Genetics 1984 17 1 111 121 (Pubitemid 14185056)
17. Lachiewicz A. M., Dawson D. V., Do young boys with fragile X syndrome have macroorchidism? Pediatrics I 1994 93 6 992 995 (Pubitemid 24163353)
18. Musumeci S. A., Hagerman R. J., Ferri R., Bosco P., Dalla Bernardina B., Tassinari C. A., De Sarro G. B., Elia M., Epilepsy and EEG findings in males with fragile X syndrome Epilepsia 1999 40 8 1092 1099 (Pubitemid 29372623)
19. Pieretti M., Zhang F., Fu Y. H., Warren S. T., Oostra B. A., Caskey C. T., Nelson D. L., Absence of expression of the FMR-1 gene in fragile X syndrome Cell 1991 66 4 817 822 (Pubitemid 121001715)
20. Sutcliffe J. S., Nelson D. L., Zhang F., Pieretti M., Caskey C. T., Saxe D., Warren S. T., DNA methylation represses FMR-1 transcription in fragile X syndrome Human Molecular Genetics 1992 1 6 397 400
21. Laggerbauer B., Ostareck D., Keidel E. M., Ostareck-Lederer A., Fischer U., Evidence that fragile X mental retardation protein is a negative regulator of translation Human Molecular Genetics 2001 10 4 329 338 (Pubitemid 32166544)
22. Li Z., Zhang Y., Ku L., Wilkinson K. D., Warren S. T., Feng Y., The fragile X mental retardation protein inhibits translation via interacting with mRNA Nucleic Acids Research 2001 29 11 2276 2283 (Pubitemid 32514930)
23. Lu R., Wang H., Liang Z., Ku L., O'Donnell W. T., Li W., Warren S. T., Feng Y., The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development Proceedings of the National Academy of Sciences of the United States of America 2004 101 42 15201 15206 (Pubitemid 39391742)
24. Muddashetty R. S., Keli S., Gross C., Xu M., Bassell G. J., Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome Journal of Neuroscience 2007 27 20 5338 5348 (Pubitemid 46790157)
25. Zhang Y. Q., Bailey A. M., Matthies H. J. G., Renden R. B., Smith M. A., Speese S. D., Rubin G. M., Broadie K., Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function Cell 2001 107 5 591 603 (Pubitemid 34014861)
26. Tessier C. R., Broadie K., Drosophila fragile X mental retardation protein developmentally regulates activity-dependent axon pruning Development 2008 135 8 1547 1557 (Pubitemid 351753644)
27. Antar L. N., Bassell G. J., Sunrise at the synapse: the FMRP mRNP shaping the synaptic interface Neuron 2003 37 4 555 558 (Pubitemid 36262977)
28. Auerbach B. D., Bear M. F., Loss of the fragile X mental retardation protein decouples metabotropic glutamate receptor dependent priming of long-term potentiation from protein synthesis Journal of Neurophysiology 2010 104 2 1047 1051
29. Costa-Mattioli M., Sossin W. S., Klann E., Sonenberg N., Translational control of long-lasting synaptic plasticity and memory Neuron 2009 61 1 10 26
30. Huber K. M., Gallagher S. M., Warren S. T., Bear M. F., Altered synaptic plasticity in a mouse model of fragile X mental retardation Proceedings of the National Academy of Sciences of the United States of America 2002 99 11 7746 7750 (Pubitemid 34568762)
31. Pan L., Woodruff E., Liang P., Broadie K., Mechanistic relationships between Drosophila fragile X mental retardation protein and metabotropic glutamate receptor A signaling Molecular and Cellular Neuroscience 2008 37 4 747 760
32. Waung M. W., Huber K. M., Protein translation in synaptic plasticity: mGluR-LTD, fragile X Current Opinion in Neurobiology 2009 19 3 319 326
33. Zhang Y. Q., Broadie K., Fathoming fragile X in fruit flies Trends in Genetics 2005 21 1 37 45 (Pubitemid 40178848)
34. Antar L. N., Afroz R., Dictenberg J. B., Carroll R. C., Bassell G. J., Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses Journal of Neuroscience 2004 24 11 2648 2655 (Pubitemid 38380941)
35. Bear M. F., Therapeutic implications of the mGluR theory of fragile X mental retardation Genes, Brain and Behavior 2005 4 6 393 398 (Pubitemid 41192450)
36. Bear M. F., Dlen G., Osterweil E., Nagarajan N., fragile X: translation in action Neuropsychopharmacology 2008 33 1 84 87 (Pubitemid 350191335)
37. Bear M. F., Huber K. M., Warren S. T., The mGluR theory of fragile X mental retardation Trends in Neurosciences 2004 27 7 370 377 (Pubitemid 38829251)
38. Dlen G., Bear M. F., Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome Journal of Physiology 2008 586 6 1503 1508 (Pubitemid 351404955)
39. Dlen G., Carpenter R. L., Ocain T. D., Bear M. F., Mechanism-based approaches to treating fragile X Pharmacology and Therapeutics 2010 127 1 78 93
40. Dlen G., Osterweil E., Rao B. S. S., Smith G. B., Auerbach B. D., Chattarji S., Bear M. F., Correction of fragile X syndrome in mice Neuron 2007 56 6 955 962 (Pubitemid 350251119)
41. Meredith R. M., de Jong R., Mansvelder H. D., Functional rescue of excitatory synaptic transmission in the developing hippocampus in Fmr1-KO mouse Neurobiology of Disease 2011 41 1 104 110
42. Pan L., Zhang Y. Q., Woodruff E., Broadie K., The Drosophila fragile X gene negatively regulates neuronal elaboration and synaptic differentiation Current Biology 2004 14 20 1863 1870 (Pubitemid 39408777)
43. Repicky S., Broadie K., Metabotropic glutamate receptor-mediated use-dependent down-regulation of synaptic excitability involves the fragile X mental retardation protein Journal of Neurophysiology 2009 101 2 672 687
44. Bolduc F. V., Bell K., Cox H., Broadie K. S., Tully T., Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory Nature Neuroscience 2008 11 10 1143 1145
45. Choi C. H., McBride S. M. J., Schoenfeld B. P., Liebelt D. A., Ferreiro D., Ferrick N. J., Hinchey P., Kollaros M., Rudominer R. L., Terlizzi A. M., Koenigsberg E., Wang Y., Sumida A., Nguyen H. T., Bell A. J., McDonald T. V., Jongens T. A., Age-dependent cognitive impairment in a Drosophila fragile X model and its pharmacological rescue Biogerontology 2010 11 3 347 362
46. McBride S. M. J., Choi C. H., Wang Y., Liebelt D., Braunstein E., Ferreiro D., Sehgal A., Siwicki K. K., Dockendorff T. C., Nguyen H. T., McDonald T. V., Jongens T. A., Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome Neuron 2005 45 5 753 764 (Pubitemid 40320709)
47. Pan L., Broadie K. S., Drosophila fragile X mental retardation protein and metabotropic glutamate receptor a convergently regulate the synaptic ratio of ionotropic glutamate receptor subclasses Journal of Neuroscience 2007 27 45 12378 12389 (Pubitemid 350085484)
48. Levenga J., de Vrij F. M. S., Oostra B. A., Willemsen R., Potential therapeutic interventions for fragile X syndrome Trends in Molecular Medicine 2010 16 11 516 527
49. Wang L. W., Berry-Kravis E., Hagerman R. J., fragile X: leading the way for targeted treatments in autism Neurotherapeutics 2010 7 3 264 274
50. Berry-Kravis E., Sumis A., Hervey C., Nelson M., Porges S. W., Weng N., Weiler I. J., Greenough W. T., Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome Journal of Developmental and Behavioral Pediatrics 2008 29 4 293 302
51. Bilousova T. V., Dansie L., Ngo M., Aye J., Charles J. R., Ethell D. W., Ethell I. M., Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model Journal of Medical Genetics 2009 46 2 94 102
52. Paribello C., Tao L., Folino A., Berry-Kravis E., Tranfaglia M., Ethell I. M., Ethell D. W., Open-label add-on treatment trial of minocycline in fragile X syndrome BMC Neurology 2010 10, article 91
53. Siller S. S., Broadie K., Neural circuit architecture defects in a Drosophila model of fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase Disease Models and Mechanisms 2011 4 5 673 685
54. Utari A., Chonchaiya W., Rivera S. M., Schneider A., Hagerman R. J., Faradz S. M., Ethell I. M., Nguyen D. V., Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures American journal on intellectual and developmental disabilities 2010 115 5 433 443
55. Kim H. S., Suh Y. H., Minocycline and neurodegenerative diseases Behavioural Brain Research 2009 196 2 168 179
56. Griffin M. O., Fricovsky E., Ceballos G., Villarreal F., Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature American Journal of Physiology-Cell Physiology 2010 299 3 C539 C548
57. Agrawal S. M., Lau L., Yong V. W., MMPs in the central nervous system: where the good guys go bad Seminars in Cell and Developmental Biology 2008 19 1 42 51 (Pubitemid 350235982)
58. Ethell I. M., Ethell D. W., Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets Journal of Neuroscience Research 2007 85 13 2813 2823 (Pubitemid 47523564)
59. Page-McCaw A., Ewald A. J., Werb Z., Matrix metalloproteinases and the regulation of tissue remodelling Nature Reviews Molecular Cell Biology 2007 8 3 221 233
60. Page-McCaw A., Serano J., Sant J. M., Rubin G. M., Drosophila matrix metalloproteinases are required for tissue remodeling, but not embryonic development Developmental Cell 2003 4 1 95 106 (Pubitemid 36105336)
61. Brundula V., Rewcastle N. B., Metz L. M., Bernard C. C., Yong V. W., Targeting leukocyte MMPs and transmigration minocycline as a potential therapy for multiple sclerosis Brain 2002 125 part 6 1297 1308 (Pubitemid 34587139)
62. van den Bosch L., Tilkin P., Lemmens G., Robberecht W., Minocycline delays disease onset and mortality in a transgenic model of ALS NeuroReport 2002 13 8 1067 1070 (Pubitemid 34587742)
63. Zhu S., Stavrovskaya I. G., Drozda M., Kim B. Y. S., Ona V., Li M., Sarang S., Liu A. S., Hartley D. M., Wu D. C., Guilans S., Ferrante R. J., Przedborski S., Kristal B. S., Friedlander R. M., Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice Nature 2002 417 6884 74 78 (Pubitemid 34498818)
64. Wang X., Zhu S., Drozda M., Zhang W., Stavrovskaya I. G., Cattaneo E., Ferrante R. J., Kristal B. S., Friedlander R. M., Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease Proceedings of the National Academy of Sciences of the United States of America 2003 100 18 10483 10487 (Pubitemid 37071904)
65. Wu D. C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D. K., Ischiropoulos H., Przedborski S., Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease Journal of Neuroscience 2002 22 5 1763 1771 (Pubitemid 35386294)
66. Choi Y., Kim H. S., Shin K. Y., Kim E. M., Kim M., Kim H. S., Park C. H., Jeong Y. H., Yoo J., Lee J. P., Chang K. A., Kim S., Suh Y. H., Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models Neuropsychopharmacology 2007 32 11 2393 2404 (Pubitemid 47587688)
67. Rivera S., Khrestchatisky M., Kaczmarek L., Rosenberg G. A., Jaworski D. M., Metzincin proteases and their inhibitors: foes or friends in nervous system physiology? Journal of Neuroscience 2010 30 46 15337 15357
68. Crocker S. J., Pagenstecher A., Campbell I. L., The TIMPs tango with MMPs and more in the central nervous system Journal of Neuroscience Research 2004 75 1 1 11 (Pubitemid 38049401)
69. Stetler-Stevenson W. G., Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities Science signaling 2008 1 27 re6
70. Rotschafer S. E., Trujillo M. S., Dansie L. E., Ethell I. M., Razak K. A., Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of fragile X syndrome Brain Research 2012 1439 7 14
71. Bakker C. E., Verheij C., Willemsen R., Van der Helm R., Oerlemans F., Vermey M., Bygrave A., Hoogeveen A. T., Oostra B. A., Reyniers E., De Boulle K., D'Hooge R., Cras P., Van Velzen D., Nagels G., Martin J. J., De Deyn P. P., Darby J. K., Willems P. J., Fmr1 knockout mice: a model to study fragile X mental retardation Cell 1994 78 1 23 33 (Pubitemid 24228297)
72. Kooy R. F., D'Hooge R., Reyniers E., Transgenic mouse model for the fragile X syndrome American Journal of Medical Genetics 1996 64 2 241 245
73. Heulens I., Kooy F., fragile X syndrome: from gene discovery to therapy Frontiers in Bioscience 2011 16 4 1211 1232
74. Hinton V. J., Brown W. T., Wisniewski K., Rudelli R. D., Analysis of neocortex in three males with the fragile X syndrome American Journal of Medical Genetics 1991 41 3 289 294
75. Rudelli R. D., Brown W. T., Wisniewski K., Adult fragile X syndrome. Clinico-neuropathologic findings Acta Neuropathologica 1985 67 3-4 289 295 (Pubitemid 15040840)
76. Ethell I. M., Pasquale E. B., Molecular mechanisms of dendritic spine development and remodeling Progress in Neurobiology 2005 75 3 161 205 (Pubitemid 40693130)
77. Knott G. W., Holtmaat A., Wilbrecht L., Welker E., Svoboda K., Spine growth precedes synapse formation in the adult neocortex in vivo Nature Neuroscience 2006 9 9 1117 1124 (Pubitemid 44306304)
78. Marrs G. S., Green S. H., Dailey M. E., Rapid formation and remodeling of postsynaptic densities in developing dendrites Nature Neuroscience 2001 4 10 1006 1013 (Pubitemid 32924140)
79. Ziv N. E., Smith S. J., Evidence for a role of dendritic filopodia in synaptogenesis and spine formation Neuron 1996 17 1 91 102 (Pubitemid 26251594)
80. Comery T. A., Harris J. B., Willems P. J., Oostra B. A., Irwin S. A., Weiler I. J., Greenough W. T., Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits Proceedings of the National Academy of Sciences of the United States of America 1997 94 10 5401 5404 (Pubitemid 27214795)
81. Nimchinsky E. A., Oberlander A. M., Svoboda K., Abnormal development of dendritic spines in FMR1 knock-out mice Journal of Neuroscience 2001 21 14 5139 5146 (Pubitemid 32622939)
82. Bilousova T. V., Rusakov D. A., Ethell D. W., Ethell I. M., Matrix metalloproteinase-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation Journal of Neurochemistry 2006 97 1 44 56
83. Bushey D., Tononi G., Cirelli C., The drosophila fragile X mental retardation gene regulates sleep need Journal of Neuroscience 2009 29 7 1948 1961
84. Coffee R. L., Tessier C. R., Woodruff E. A., Broadie K., fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P DMM Disease Models and Mechanisms 2010 3 7-8 471 485
85. Dockendorff T. C., Su H. S., McBride S. M. J., Yang Z., Choi C. H., Siwicki K. K., Sehgal A., Jongens T. A., Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest Neuron 2002 34 6 973 984 (Pubitemid 34722286)
86. Gatto C. L., Broadie K., Temporal requirements of the fragile X mental retardation protein in the regulation of synaptic structure Development 2008 135 15 2637 2642
87. Gatto C. L., Broadie K., Temporal requirements of the fragile X mental retardation protein in modulating circadian clock circuit synaptic architecture Front Neural Circuits 2009 3 8
88. Gatto C. L., Broadie K., The fragile X mental retardation protein in circadian rhythmicity and memory consolidation Molecular Neurobiology 2009 39 2 107 129
89. Inoue S. B., Shimoda M., Nishinokubi I., Siomi M. C., Okamura M., Nakamura A., Kobayashi S., Ishida N., Siomi H., A role for the Drosophila fragile X-related gene in circadian output Current Biology 2002 12 15 1331 1335 (Pubitemid 34869885)
90. Morales J., Hiesinger P. R., Schroeder A. J., Kume K., Verstreken P., Jackson F. R., Nelson D. L., Hassan B. A., Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brain Neuron 2002 34 6 961 972 (Pubitemid 34722285)
91. Tessier C. R., Broadie K., The fragile X mental retardation protein developmentally regulates the strength and fidelity of calcium signaling in Drosophilas mushroom body neurons Neurobiology of Disease 2011 41 1 147 159
92. Zhang Y. Q., Matthies H. J. G., Mancuso J., Andrews H. K., Woodruff E., Friedman D., Broadie K., The Drosophila fragile X-related gene regulates axoneme differentiation during spermatogenesis Developmental Biology 2004 270 2 290 307 (Pubitemid 38748554)
93. Callan M. A., Cabernard C., Heck J., Luois S., Doe C. Q., Zarnescu D. C., fragile X protein controls neural stem cell proliferation in the Drosophila brain Human molecular genetics 2010 19 15 3068 3079
94. Cziko A. M. J., McCann C. T., Howlett I. C., Barbee S. A., Duncan R. P., Luedemann R., Zarnescu D., Zinsmaier K. E., Parker R. R., Ramaswami M., Genetic modifiers of dFMR1 encode RNA granule components in Drosophila Genetics 2009 182 4 1051 1060
95. Epstein A. M., Bauer C. R., Ho A., Bosco G., Zarnescu D. C., Drosophila fragile X protein controls cellular proliferation by regulating cbl levels in the ovary Developmental Biology 2009 330 1 83 92
96. Estes P. S., O'Shea M., Clasen S., Zarnescu D. C., fragile X protein controls the efficacy of mRNA transport in Drosophila neurons Molecular and Cellular Neuroscience 2008 39 2 170 179
97. Chang S., Bray S. M., Li Z., Zarnescu D. C., He C., Jin P., Warren S. T., Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila Nature Chemical Biology 2008 4 4 256 263 (Pubitemid 351419125)
98. Zarnescu D. C., Shan G., Warren S. T., Jin P., Come FLY with us: toward understanding fragile X syndrome Genes, Brain and Behavior 2005 4 6 385 392 (Pubitemid 41192449)
99. Coffee R. L. Jr., Williamson A. J., Adkins C. M., Gray M. C., Page T. L., Broadie K., In vivo neuronal function of the fragile X mental retardation protein is regulated by phosphorylation. Human Molecular Genetics. In press
100. Michaluk P., Wawrzyniak M., Alot P., Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology Journal of Cell Science 2011 124, part 19 3369 3380
101. Page-McCaw A., Remodeling the model organism: matrix metalloproteinase functions in invertebrates Seminars in Cell and Developmental Biology 2008 19 1 14 23
102. Glasheen B. M., Kabra A. T., Page-McCaw A., Distinct functions for the catalytic and hemopexin domains of a Drosophila matrix metalloproteinase Proceedings of the National Academy of Sciences of the United States of America 2009 106 8 2659 2664
103. Glasheen B. M., Robbins R. M., Piette C., Beitel G. J., Page-McCaw A., A matrix metalloproteinase mediates airway remodeling in Drosophila Developmental Biology 2010 344 2 772 783
104. Michaluk P., Kaczmarek L., Matrix metalloproteinase-9 in glutamate-dependent adult brain function and dysfunction Cell Death and Differentiation 2007 14 7 1255 1258 (Pubitemid 46969864)
105. Nagy V., Bozdagi O., Matynia A., Balcerzyk M., Okulski P., Dzwonek J., Costa R. M., Silva A. J., Kaczmarek L., Huntley G. W., Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory Journal of Neuroscience 2006 26 7 1923 1934
106. Tian L., Stefanidakis M., Ning L., Van Lint P., Nyman-Huttunen H., Libert C., Itohara S., Mishina M., Rauvala H., Gahmberg C. G., Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage Journal of Cell Biology 2007 178 4 687 700 (Pubitemid 47267279)
107. Gawlak M., Grkiewicz T., Gorlewicz A., Konopacki F. A., Kaczmarek L., Wilczynski G. M., High resolution in situ zymography reveals matrix metalloproteinase activity at glutamatergic synapses Neuroscience 2009 158 1 167 176
108. Konopacki F. A., Rylski M., Wilczek E., Amborska R., Detka D., Kaczmarek L., Wilczynski G. M., Synaptic localization of seizure-induced matrix metalloproteinase-9 mRNA Neuroscience 2007 150 1 31 39 (Pubitemid 350198686)
109. Duchossoy Y., Horvat J. C., Stettler O., MMP-related gelatinase activity is strongly induced in scar tissue of injured adult spinal cord and forms pathways for ingrowing neurites Molecular and Cellular Neuroscience 2001 17 6 945 956 (Pubitemid 32641865)
110. Moore C. S., Crocker S. J., An alternate perspective on the roles of TIMPs and MMPs in pathology The American Journal of Pathology 2012 180 1 12 16
111. Le A. P., Friedman W. J., Matrix metalloproteinase-7 regulates cleavage of pro-nerve growth factor and is neuroprotective following kainic acid-induced seizures The Journal of Neuroscience 2012 32 2 703 712
112. de Maria A., Solaro C., Abbruzzese M., Primavera A., Minocycline for symptomatic neurosyphilis in patients allergic to penicillin The New England Journal of Medicine 1997 337 18 1322 1323 (Pubitemid 27461296)
113. Hayashi N., Kawashima M., Efficacy of oral antibiotics on acne vulgaris and their effects on quality of life: a multicenter randomized controlled trial using minocycline, roxithromycin and faropenem Journal of Dermatology 2011 38 2 111 119
114. Moult P. R., Corra S. A. L., Collingridge G. L., Fitzjohn S. M., Bashir Z. I., Co-activation of p38 mitogen-activated protein kinase and protein tyrosine phosphatase underlies metabotropic glutamate receptor-dependent long-term depression Journal of Physiology 2008 586 10 2499 2510 (Pubitemid 351689808)
115. Pi R., Li W., Lee N. T. K., Chan H. H. N., Pu Y., Ling N. C., Sucher N. J., Chang D. C., Li M., Han Y., Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways Journal of Neurochemistry 2004 91 5 1219 1230 (Pubitemid 39587460)